MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.
| Revenue (TTM) | $8.07B |
| Gross Profit (TTM) | $2.02B |
| EBITDA | $149.08M |
| Operating Margin | -25.80% |
| Return on Equity | 53.20% |
| Return on Assets | -1.78% |
| Revenue/Share (TTM) | $1221.72 |
| Book Value | $0.19 |
| Price-to-Book | 5.63 |
| Price-to-Sales (TTM) | 0.00 |
| EV/Revenue | 0.65 |
| EV/EBITDA | 15.31 |
| Quarterly Earnings Growth (YoY) | 27.80% |
| Quarterly Revenue Growth (YoY) | -6.70% |
| Shares Outstanding | $7.90M |
| Float | $5.79M |
| % Insiders | 26.42% |
| % Institutions | 0.74% |
Volatility is currently contracting
Additional Orders Triple Implementation Scale; "MOTHER Bracelet®" Enables Continuous Safety Monitoring During Extended Training Additional Orders Triple Implementation Scale; "MOTHER Bracelet®" Enables Continuous Safety Monitoring During Extended Training
Toronto, Ontario and New York, New York--(Newsfile Corp. - June 23, 2026) - Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) ("Micromem" or the "Company") is pleased to provide an update following recent meetings with representatives of the Department of National Defence ("DND"). The Company has now completed its initial cost analysis and engineering review of the wearable unit prototype.
Toronto, Ontario and New York, New York--(Newsfile Corp. - June 18, 2026) - Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) ("Micromem" or the "Company") announces closing of its non-brokered private placement (the "Private Placement") previously announced in its news release issued on June 9, 2026. Micromem raised gross proceeds of approximately C$235,000 by placing a total of 9,400,000 units at a price of C$0.025 per unit, each unit being comprised of one common share and one warrant exercisable at C$0.05 per share for a period of two years following the issuance date.
